Hypertensive patients show delayed wound healing following total hip arthroplasty

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Ahmed, Awad A ^a   Mooar, Pekka A ^b   Kleiner, Matthew ^b   Torg, Joseph S ^b   Miyamoto, Curtis T ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TOTAL HIP PROSTHESIS; WOUND HEALING; WOUND HEALING IMPAIRMENT; BLOOD PRESSURE; HIP ARTHROPLASTY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; WOUND HEALING;

EID: 80051629621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023224     Document Type: Article

References (34)

1. Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A, (2010) National hospital discharge survey: 2007 summary. National Health Statistics Report 29.
2. Jain N, Guller U, Pietrobon R, Bond T, Higgins L, (2005) Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat R 435: 232-8.
3. Saleh K, Olson M, Resig S, Bershadsky B, Kuskowski M, et al. (2002) Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res 20: 506-515.
4. Hanssen AD, Rand JA, (1998) Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg Am 80: 910-22.
5. Cordero-Ampuero J, de Dios M, (2010) What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties? Clin Orthop Relat R 468: 3269-3277.
6. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, et al. (2007) Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 89: 33-37.
7. Surin V, Sundholm K, Bäckmann L, (1983) Infection after total hip replacement with special reference to a discharge from the wound. J Bone and Joint Surg Brit 65b: 412-418.
8. Health, United States, 2009: With special feature on medical technology.(2010).
9. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (jnc v). (1993). Arch Intern Med 153: 154-183.
10. Steiner M, (1999) Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease. Nutr Rev 57: 306-9.
11. Spencer A, (2000) Vitamin E: cautionary issues. Curr Treat Options Cardiovasc Med 2: 1-3.
12. Chen J, He J, Hamm L, Batuman V, Whelton PK, (2002) Serum antioxidant vitamins and blood pressure in the United States population. Hypertension 40: 810.
13. Lavie CJ, Schmieder RE, Messerli FH, (1988) Ambulatory blood pressure monitoring: Practical considerations. American Heart Journal 116: 1146-1151.
14. Weiss APC, Krackow KA, (1993) Persistent wound drainage after primary total knee arthroplasty. The Journal of Arthroplasty 8: 285-289.
15. Rosenbaum P, Rubin D, (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55.
16. Stuart E, Green K, (2008) Using full matching to estimate causal effects in nonexperimental studies: examining the relationship between adolescent marijuana use and adult outcomes. Developmental Psychology 442: 95-406.
17. Rosenbaum P, (1989) Optimal matching for observational studies. Journal of the American Statistical Association 84: 1024-32.
18. Gu X, Rosenbaum P, (1993) Comparison of multivariate matching methods: structures, distances, and algorithms. J of Comput Graph Stat 2: 405-420.
19. Imai K, King G, Lau O, (2008) Logit: logistic regression for dichotomous dependent variables. Zelig: Everyone's Statistical Software.
20. Rubin D, (2001) Using propensity scores to help design observational studies: application to the tobacco litigation. Health Services and Outcomes Research Methodology 2: 169-188.
21. Colwell CW, Collis DK, Paulson R, McCutchen JW, Bigler GT, et al. (1999) Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. J Bone Joint Surg 81: 932-940.
22. Colwell CW, Froimson MI, Mont MA, Ritter MA, Trousdale RT, et al. (2010) Thrombosis prevention after total hip arthroplasty. J Bone Joint Surg 92: 527-535.
23. Bergqvist D, Benoni G, Björgell O, Fredin H, Hedlundh U, et al. (1996) Low molecular weight heparin as prophylaxis against venous thrombosis after total hip replacement. N Engl J Med 335: 696-700.
24. Murray D, Britton A, Bulstrode C, (1996) Thromboprophylaxis and death after total hip replacement. J Bone and Joint Surg Brit 78B: 863-870.
25. Clagett GP, Anderson FA, Levine MN, Salzman EW, Wheeler HB, (1992) Prevention of venous thromboembolism. Chest 102: 391S-407S.
26. Colwell CW, Spiro TE, Trowbridge AA, Morris BA, Kwann HC, et al. (1994) Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. J Bone Joint Surg Am 76: 3-14.
27. Erickson B, Erickson E, Risberg B, (1991) Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients. Thromb Res 62: 55-64.
28. Choonara I, Malia R, Haynes B, Hay C, Cholerton S, et al. (1988) The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br J Clin Pharmacol 25: 1-7.
29. Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM, (1998) Low-molecular-weight heparins: pharmacologic profile and product differentiation. Am J Cardiol 82: 3L-10L.
30. Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, et al. (1998) Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 114: 489S-510S.
31. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, et al. (2005) Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 87: 84-50.
32. Lai K, Bohm ER, Burnell C, Hedden DR, (2007) Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty 22: 651-56.
33. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, et al. (2008) Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 23: 984-91.
34. Lübbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P, (2007) Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum 57: 327-34.